News + Filings Holdings
|
VANGUARD GROUP INC
> AKBA
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Akebia Therapeutics, Inc. | AKBA | 7,811,061 | -5,371,804 | 7,147,121,000 | 7,142,953,000 | $915.00 |
09/30/2022 | Akebia Therapeutics, Inc. | AKBA | 13,182,865 | -3,076,239 | 4,168,000 | -1,573,000 | $0.32 |
06/30/2022 | Akebia Therapeutics, Inc. | AKBA | 16,259,104 | 1,856,116 | 5,741,000 | -4,598,000 | $0.35 |
03/31/2022 | Akebia Therapeutics, Inc. | AKBA | 14,402,988 | 1,167,319 | 10,339,000 | -19,575,000 | $0.72 |
12/31/2021 | Akebia Therapeutics, Inc. | AKBA | 13,235,669 | 824,426 | 29,914,000 | -5,831,000 | $2.26 |
09/30/2021 | Akebia Therapeutics, Inc. | AKBA | 12,411,243 | 255,524 | 35,745,000 | -10,326,000 | $2.88 |
06/30/2021 | Akebia Therapeutics, Inc. | AKBA | 12,155,719 | 3,720,960 | 46,071,000 | 22,454,000 | $3.79 |
02/10/2021 | Akebia Therapeutics, Inc. | AKBA | 8,434,759 | 0 | 38,968,587 | 15,351,587 | $4.62 |
12/31/2020 | Akebia Therapeutics, Inc. | AKBA | 8,434,759 | 1,869,694 | 23,617,000 | 7,139,000 | $2.80 |
09/30/2020 | Akebia Therapeutics, Inc. | AKBA | 6,565,065 | -755,811 | 16,478,000 | -82,939,000 | $2.51 |
06/30/2020 | Akebia Therapeutics, Inc. | AKBA | 7,320,876 | 1,435,322 | 99,417,000 | 54,804,000 | $13.58 |
03/31/2020 | Akebia Therapeutics, Inc. | AKBA | 5,885,554 | 365,374 | 44,613,000 | 9,725,000 | $7.58 |
12/31/2019 | Akebia Therapeutics, Inc. | AKBA | 5,520,180 | 54,123 | 34,888,000 | 13,461,000 | $6.32 |
09/30/2019 | Akebia Therapeutics, Inc. | AKBA | 5,466,057 | 296,126 | 21,427,000 | -3,596,000 | $3.92 |
06/30/2019 | Akebia Therapeutics, Inc. | AKBA | 5,169,931 | -633,438 | 25,023,000 | -22,505,000 | $4.84 |
03/31/2019 | Akebia Therapeutics, Inc. | AKBA | 5,803,369 | 896,018 | 47,528,000 | 20,390,000 | $8.19 |
12/31/2018 | Akebia Therapeutics, Inc. | AKBA | 4,907,351 | 2,349,768 | 27,138,000 | 4,555,000 | $5.53 |
09/30/2018 | Akebia Therapeutics, Inc. | AKBA | 2,557,583 | -17,771 | 22,583,000 | -3,119,000 | $8.83 |
06/30/2018 | Akebia Therapeutics, Inc. | AKBA | 2,575,354 | 216,165 | 25,702,000 | 3,220,000 | $9.98 |
03/31/2018 | Akebia Therapeutics, Inc. | AKBA | 2,359,189 | 417,987 | 22,482,000 | -6,384,000 | $9.53 |
12/31/2017 | Akebia Therapeutics, Inc. | AKBA | 1,941,202 | 220,184 | 28,866,000 | -4,986,000 | $14.87 |
09/30/2017 | Akebia Therapeutics, Inc. | AKBA | 1,721,018 | 284,855 | 33,852,000 | 33,831,362 | $19.67 |
06/30/2017 | Akebia Therapeutics, Inc. | AKBA | 1,436,163 | 134,283 | 20,638 | -11,956,362 | $0.01 |
03/31/2017 | Akebia Therapeutics, Inc. | AKBA | 1,301,880 | 105,645 | 11,977,000 | -476,000 | $9.20 |
12/31/2016 | Akebia Therapeutics, Inc. | AKBA | 1,196,235 | 43,772 | 12,453,000 | 2,023,000 | $10.41 |
09/30/2016 | Akebia Therapeutics, Inc. | AKBA | 1,152,463 | 1,152,463 | 10,430,000 | 10,430,000 | $9.05 |
06/30/2016 | Akebia Therapeutics, Inc. | AKBA | 1,085,393 | 67,246 | 8,118,000 | -1,055,000 | $7.48 |
03/31/2016 | Akebia Therapeutics, Inc. | AKBA | 1,018,147 | 404,310 | 9,173,000 | 3,243,000 | $9.01 |
12/31/2015 | Akebia Therapeutics, Inc. | AKBA | 689,282 | 75,445 | 8,905,000 | 2,975,000 | $12.92 |
09/30/2015 | Akebia Therapeutics, Inc. | AKBA | 4,658,438 | 4,164,809 | 185,705,000 | 180,626,000 | $39.86 |
06/30/2015 | Akebia Therapeutics, Inc. | AKBA | 493,629 | 205,787 | 5,079,000 | 1,881,000 | $10.29 |
03/31/2015 | Akebia Therapeutics, Inc. | AKBA | 287,842 | 56,517 | 3,198,000 | 505,000 | $11.11 |
12/31/2014 | Akebia Therapeutics, Inc. | AKBA | 231,325 | 67,214 | 2,693,000 | -938,000 | $11.64 |
09/30/2014 | Akebia Therapeutics, Inc. | AKBA | 164,111 | 164,111 | 3,631,000 | 3,631,000 | $22.13 |
06/30/2014 | Akebia Therapeutics, Inc. | AKBA | 147,874 | 147,874 | 4,110,000 | 4,110,000 | $27.79 |
<< Prev Next >> |
|